FDA cleared the Charlotte ACC25 Surface Electrode Array; Charlotte ACC25 Reusable Surface Electrode Array from Cadwell Industries, Inc. on Jun 26, 2026 under K261442, a abbreviated 510(k). The device falls under product code GXY, Electrode, Cutaneous, regulated at 21 CFR 882.1320 as a Class 2 device. The review panel was Neurology.

FDA logged the submission as received on Apr 30, 2026. The decision came 57 days later, inside the 90 FDA-day goal for a 510(k).

Cadwell Industries, Inc. has one other decision in the tracker over the last 12 months: K250851 (Hypnos (369054-200)).